Despite waning demand from adults in developed countries for vaccines,pharmaceutical glass manufacturers have invested heavily in expanding capacity to combat the COVID-19 pandemic,writes Rohan Gunasekera.In addition,he believes their confidence may have been boosted by changes related to health trends,including the increased use of biologies and self-medication.
展开▼